Growdea Technologies Pvt Ltd
Growdea Technologies is a pioneering startup, established in 2018 and originating from the Indian Institute of Technology, Delhi. Founded by Dr. Avinash Mishra and Professor Anurag Singh Rathore, the company specializes in in-silico drug discovery and computational biology services, leveraging AI and machine learning for accelerated drug discovery. Their expertise encompasses virtual screening, molecular modeling, chemoinformatics, molecular dynamics simulations, target identification, systems biology analysis, and proteomics/genomics data insights. Growdea excels in protein-ligand interactions, molecular docking, structural prediction via ML, AI-assisted drug repurposing, virtual screening, and antibody optimization, with a focus on drug-target network analysis, personalized medicine informatics, and biomarker discovery. As an Indian Contract Research Organization (CRO), Growdea offers comprehensive drug discovery services from screening to chemistry, aiming to accelerate advancements in pharmaceuticals through the integration of AI, ML, biology, and drug design.
Growdea Technologies Pvt Ltd
Growdea Technologies is a pioneering startup, established in 2018 and originating from the Indian Institute of Technology, Delhi. Founded by Dr. Avinash Mishra and Professor Anurag Singh Rathore, the company specializes in in-silico drug discovery and computational biology services, leveraging AI and machine learning for accelerated drug discovery. Their expertise encompasses virtual screening, molecular modeling, chemoinformatics, molecular dynamics simulations, target identification, systems biology analysis, and proteomics/genomics data insights. Growdea excels in protein-ligand interactions, molecular docking, structural prediction via ML, AI-assisted drug repurposing, virtual screening, and antibody optimization, with a focus on drug-target network analysis, personalized medicine informatics, and biomarker discovery. As an Indian Contract Research Organization (CRO), Growdea offers comprehensive drug discovery services from screening to chemistry, aiming to accelerate advancements in pharmaceuticals through the integration of AI, ML, biology, and drug design.